SDS Optic Spolka Akcyjna

zł 2.98As of Sun 8 Nov 2026, 12:00 UTC

WSE:SDSHealthcare

Country Poland

PE (Fwd) 10.56

TSR 5Y CAGR (22.60%)

Div yield —

ROE (217.45%)

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM (56.30%)

Mkt cap zł 19.89M

ROIC (544.62%)

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

zł 3.26

9.38%

(63.23%)

Price above Reference Value

TTM

FYE 31 Dec PLN

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

1.057

Revenuezł M

—

0.849

—

◌—

0.753

1.494

(3.92%)

—

Revenue growth%

—

(99.61)

—

98.47

(99.61)

—

150.50

Gross margin%

—

(210.88)

74937.00

—

366.55

(100.00)

366.55

—

(159.52)

Operating margin%

—

(392.39)

(116574.16)

—

(270.56)

(100.00)

(392.39)

—

(269.37)

Net margin%

—

(463.77)

(103938.74)

—

(370.19)

100.00

(463.77)

—

P/E ratio (avg)x

—

12.56

—

EV/EBITx

—

(30.65)

FCF yield (avg)%

—

(21.47)

(6.45)

(10.87)

(20.23)

7.96

(15.55)

—

(577.06)

FCF margin%

—

(1482.47)

(311649.54)

—

(987.58)

100.00

(1482.47)

—

2.142

FCF / Net incomex

—

3.197

2.998

2.238

2.668

1.000

2.833

—

(544.62)

ROIC%

—

(61.09)

(39.04)

(14.64)

(482.82)

(50.06)

—

(217.45)

Return on equity%

—

(61.47)

(46.38)

(83.32)

(109.71)

88.67

(72.40)

—

(16.62)

Return on assets%

—

(49.55)

(36.88)

(28.80)

(16.72)

8.36

(32.84)

—

(0.43)

EPSzł

—

(0.74)

(0.59)

(0.85)

(0.44)

0.24

—

EPS growth%

—

19.86

(43.70)

48.03

153.61

19.86

—

0.20

Bookvalue per shzł

—

1.20

1.47

0.59

0.25

0.33

(40.85%)

—

(0.91)

FCF per sharezł

—

(2.36)

(1.78)

(1.91)

(1.18)

0.24

—

Dividend per shzł

—

Div yield (avg)%

—

Payout ratio%

—

6.675

Shares (diluted)M

—

5.326

5.878

5.933

6.300

◌6.300

5.76%

—

Buyback yield%

—

(10.35)

(0.95)

(6.19)

◌—

(6.19)

—

D/E ratiox

—

3.717

8.811

—

1.858

—

18.82

Enterprise valuezł M

—

57.67

160.6

114.1

49.50

17.02

(4.96%)

—

LT debtzł M

—

13.06

13.82

—

5.80%

—

Peers (US$4.255M)

Cap (US$)

Milton Essex Spólka…

8.346M

—

Grupa Modne Zakupy S.A.

5.788M

—

InventionMed S.A.

5.531M

20.95x

Surgical Innovations…

4.079M

—

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

(1.799)

(18,657)

Own earn%

—

Sh yield%

—

(6.19)

Owners

Insiders/Inst%

4.81

2.65

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

—

EPS growth years

2/3

Dividend streakyrs

Op margin range%

−116574–−271

$1 testx

—

Incr. ROIC%

—

SDS Optic Spolka Akcyjna discovers, develops, produces, and commercializes diagnostics and monitoring tools worldwide. It offers inPROBE, a cancer diagnostics and treatment device that measure the level of active ingredients in cancer tumor cells. The company is also involved in the modeling and designing of package components, such as ferrules, housings, and other devices with flat and conical surface areas.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

zł 0.753M

(3.92%)

1.00×

Operating expenses

zł 4.797M

46.01%

3.51×

Asset mix

Trend

Other

93.54%

Cash and investments

6.45%

Reinvestment returns

No breakdown available